Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF for diabetic foot ulcer
IRCT20210212050334N2Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose stromal vascular fraction in diabetic foot ulcer (DFU) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Safety of stromal vascular fraction. Started Dec 2021; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20210212050334N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210212050334N2.